Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72 K. IrvineJ. Schlom Original articles Pages: 281 - 292
Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking Venkatesh RamakrishnaAvi EisenthalMeir Shinitzky Original articles Pages: 293 - 299
Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking Avi EisenthalVenkatesh RamakrishnaMeir Shinitzky Original articles Pages: 300 - 306
Resistance ofHER2/neu-overexpressing tumor targets to lymphokine-activated-killer-cell-mediated lysis: evidence for deficiency of binding and post-binding events Catherine FadyAgnes GardnerAlan Lichtenstein Original articles Pages: 307 - 314
Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2 Flavio ArientiFiliberto BelliNatale Cascinelli Original articles Pages: 315 - 322
Prevention of lymph node metastases by adoptive transfer of CD4+ T lymphocytes admixed with irradiated tumor cells Kikuyoshi YoshidaTakehiko Tachibana Original articles Pages: 323 - 330
Heterogeneous binding and killing behaviour of human γ/δ-TCR+ lymphokine-activated killer cells against K562 and Daudi cells Iren VollenweiderEva VrbkaPeter Groscurth Original articles Pages: 331 - 336
Development of a bispecific monoclonal antibody against a gallium-67 chelate and the human melanoma-associated antigen p97 for potential use in pretargeted immunoscintigraphy Chezian SomasundaramSiegfried MatzkuMargot Zöller Original articles Pages: 337 - 345
In vitro and in vivo properties of an anti-CD5—momordin immunotoxin on normal and neoplastic T lymphocytes G. PorroA. BolognesiD. Modena Short communication Pages: 346 - 350
